ARTICLE | Clinical News
Terbinafine: Phase II started
October 22, 2007 7:00 AM UTC
Celtic began a Phase II trial of topical terbinafine. The company has exclusive rights to IDEA's Transfersome technology (see BioCentury, Feb. 27, 2006). Novartis AG (NVS; SWX:NOVN, Basel, Switzerlan...